Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • PD-1/PD-L1
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

durvalumab

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
Durvalumab
MEDI 4736
T111261428935-60-7
Durvalumab (MEDI 4736) is a humanized monoclonal antibody targeting PD-L1. It can block the interaction of PD-L1 with PD-1 and CD80, with IC50 values of 0.1 and 0.04 nM, respectively. Durvalumab is often used in combination with platinum-based compounds for the treatment of non-small cell lung cancer and advanced hepatocellular carcinoma cells.
  • $228
In Stock
Size
QTY
Tremelimumab
Ticilimumab, CP-675206
T77466745013-59-6
Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and lung cancer.
  • $155
In Stock
Size
QTY